COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins
We have accumulated my own experience of management pregnant women with COVID-19 after assisted reproductive technologies (ART) receiving low molecular weight heparins (LMWH). All women suffered COVID-19 in mild form without respiratory failure and gave birth to healthy children. Our observations co...
Main Authors: | N. S. Stuleva, A. L. Mishchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2021-07-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/1002 |
Similar Items
-
Thrombosis risk and in vitro fertilization
by: E. Grandone
Published: (2022-03-01) -
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
by: Pasquale Paolisso, et al.
Published: (2020-08-01) -
Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
by: Gedion Yilma Amdetsion, et al.
Published: (2023-11-01) -
The Antineoplastic Effect of Heparin on Colorectal Cancer: A Review of the Literature
by: Emmanuel Giannas, et al.
Published: (2023-11-01) -
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
by: Riccardo Giossi, et al.
Published: (2021-09-01)